Literature DB >> 12875984

E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells.

Béatrice Nawrocki-Raby1, Christine Gilles, Myriam Polette, Corinne Martinella-Catusse, Noël Bonnet, Edith Puchelle, Jean-Michel Foidart, Frans Van Roy, Philippe Birembaut.   

Abstract

The disorganization of E-cadherin/catenin complexes and the overexpression of matrix metalloproteinases (MMPs) are frequently involved in the capacity of epithelial cells to acquire an invasive phenotype. The functional link between E-cadherin and MMPs was studied by transfecting invasive bronchial BZR tumor cells with human E-cadherin cDNA. Using different in vitro (cell dispersion, modified Boyden chamber) and in vivo assays (human airway epithelial xenograft), we showed that E-cadherin-positive clones displayed a decrease of invasive abilities. As shown by immunoprecipitation, the re-expressed E-cadherin was able to sequestrate one part of free cytoplasmic beta-catenin in BZR cells. The decrease of beta-catenin transcriptional activity in E-cadherin-transfected clones was demonstrated using the TOP-FLASH reporter construct. Finally, we observed a decrease of MMP-1, MMP-3, MMP-9, and MT1-MMP, both at the mRNA and at the protein levels, in E-cadherin-positive clones whereas no changes in MMP-2, TIMP-1, or TIMP-2 were observed when compared with control clones. Moreover, zymography analysis revealed a loss of MMP-2 activation ability in E-cadherin-positive clones treated with the concanavalin A lectin. These data demonstrate a direct role of E-cadherin/catenin complex organization in the regulation of MMPs and suggest an implication of this regulation in the expression of an invasive phenotype by bronchial tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875984      PMCID: PMC1868220          DOI: 10.1016/S0002-9440(10)63692-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 2.  E-cadherin-catenin cell-cell adhesion complex and human cancer.

Authors:  B P Wijnhoven; W N Dinjens; M Pignatelli
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

3.  Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade.

Authors:  T Ara; Y Deyama; Y Yoshimura; F Higashino; M Shindoh; A Matsumoto; H Fukuda
Journal:  Cancer Lett       Date:  2000-09-01       Impact factor: 8.679

4.  The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.

Authors:  H C Crawford; B Fingleton; M D Gustavson; N Kurpios; R A Wagenaar; J A Hassell; L M Matrisian
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 5.  Interstitial collagenases as markers of tumor progression.

Authors:  C E Brinckerhoff; J L Rutter; U Benbow
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

6.  Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.

Authors:  M Balduyck; F Zerimech; V Gouyer; R Lemaire; B Hemon; G Grard; C Thiebaut; V Lemaire; E Dacquembronne; T Duhem; A Lebrun; M J Dejonghe; G Huet
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Authors:  R S Herbst; S Yano; H Kuniyasu; F R Khuri; C D Bucana; F Guo; D Liu; B Kemp; J J Lee; W K Hong; I J Fidler
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

Review 8.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

9.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 10.  Regulation of cadherin adhesive activity.

Authors:  B M Gumbiner
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  34 in total

1.  BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity.

Authors:  Gongping Gu; Dejian Zhao; Ziming Yin; Ping Liu
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

2.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.

Authors:  Sandeep Kumar; Ajay K Chaudhary; Rahul Kumar; Jordan O'Malley; Anna Dubrovska; Xinjiang Wang; Neelu Yadav; David W Goodrich; Dhyan Chandra
Journal:  Mol Oncol       Date:  2016-03-31       Impact factor: 6.603

4.  microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.

Authors:  Hyun Min Cho; Hyo Sung Jeon; Soo Young Lee; Kang Jin Jeong; Soon-Young Park; Hoi Young Lee; Jung Uee Lee; Ji Hye Kim; Sun Jung Kwon; Eugene Choi; Moon Jun Na; Jaeku Kang; Ji Woong Son
Journal:  Exp Ther Med       Date:  2011-06-14       Impact factor: 2.447

5.  GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.

Authors:  Wei Yan; Qing Jackie Cao; Richard B Arenas; Brooke Bentley; Rong Shao
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

6.  Regulation of MT1-MMP activity by β-catenin in MDCK non-cancer and HT1080 cancer cells.

Authors:  Ping Liu; Jianbo Yang; Jing Pei; Duanqing Pei; Michael J Wilson
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

7.  C-reactive protein inhibits expression of N-cadherin and ZEB-1 in murine colon adenocarcinoma.

Authors:  Satoshi Kudo; Hajime Saito; Satoru Motoyama; Tomohiko Sasaki; Kazuhiro Imai; Hayato Konno; Shinogu Takashima; Maiko Atari; Yusuke Sato; Yoshihiro Minamiya
Journal:  Tumour Biol       Date:  2015-04-13

8.  Directed Evolution to Engineer Monobody for FRET Biosensor Assembly and Imaging at Live-Cell Surface.

Authors:  Praopim Limsakul; Qin Peng; Yiqian Wu; Molly E Allen; Jing Liang; Albert G Remacle; Tyler Lopez; Xin Ge; Brian K Kay; Huimin Zhao; Alex Y Strongin; Xiang-Lei Yang; Shaoying Lu; Yingxiao Wang
Journal:  Cell Chem Biol       Date:  2018-01-27       Impact factor: 8.116

Review 9.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.

Authors:  Dengfeng Cao; Kornelia Polyak; Marc K Halushka; Hind Nassar; Nina Kouprina; Christine Iacobuzio-Donahue; Xinyan Wu; Saraswati Sukumar; Jessica Hicks; Angelo De Marzo; Pedram Argani
Journal:  Breast Cancer Res       Date:  2008-10-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.